Volume: 23S7 - November 1997

CONTROLLING ANTIMICROBIAL RESISTANCE
An Integrated Action Plan for Canadians

Organized by Health Canada and
The Canadian Infectious Disease Society

Table of Contents

EXECUTIVE SUMMARY

BACKGROUND

CONFERENCE OBJECTIVES AND RECOMMENDATIONS

WORKING GROUP ISSUES

1. Antimicrobial Use

• In the community
  • Recommendation
• In acute care institutional health settings
  • Recommendations
• In chronic care settings
  • Recommendation
• Perceptions of antimicrobial use
  • Recommendations

2. Detecting Antimicrobial Resistance
   

• In the community Acute care institutional settings Long-term care facilities
  • Recommendations

3. Working Together to Create Partnerships

• Recommendations

4. Communicating and Evaluating the Action Plan

• Recommendations

CONCLUSION

REFERENCES

APPENDIX I PLANNING COMMITTEE MEMBERS

APPENDIX II LIST OF PARTICIPANTS

APPENDIX III LIST OF WORKING GROUPS

APPENDIX IV IMS DATA

APPENDIX V CONSOLIDATION OF RECOMMENDATIONS BY ISSUE

APPENDIX VI AGENDA

The Laboratory Centre for Disease Control and The Canadian Infectious Disease Society would like to thank all contributors for their support and extend their sincere appreciation to the following sponsors for supporting this consensus conference.

Major Sponsors

Health Canada
Bayer Inc
Pfizer Canada Inc
Rhône-Poulenc Rorer Canada Inc

Sponsor

Hoffman-La Roche Ltd

Health Canada and the Canadian Infectious Disease Society would like to thank the Planning Committee,the Speakers, the Chairperson, the Working Group Chairs and Rapporteurs, the Participants and LCDC staff and contractors for their invaluable contribution to this consensus conference.

[Table of Contents] [Next]